01 3Avonex
02 4Avonex
03 1Interferon
04 1Interferon (Avonex And Plegridy)
05 2Plegridy
06 2Total Interferon
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 1,878
2019 Revenue in Millions : 2,102
Growth (%) : -11
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 386
2019 Revenue in Millions : 436
Growth (%) : -12
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 1,492
2019 Revenue in Millions : 1,666
Growth (%) : -10
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 1,566
2020 Revenue in Millions : 1,878
Growth (%) : -17
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 974
2021 Revenue in Millions : 1,209
Growth (%) : -19
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 811
2022 Revenue in Millions : 974
Growth (%) : -17
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 3,013
2014 Revenue in Millions : 2,630
Growth (%) : -13%
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 2,152
2016 Revenue in Millions : 2,314
Growth (%) : -7
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 2,314
2015 Revenue in Millions : 2,630
Growth (%) : -12
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 2,363
2017 Revenue in Millions : 2,646
Growth (%) : -11%
